Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lu Gan
Observed name:
L. Gan
Institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
Observed institution:
The Affiliated Yongchuan Hospital of Chongqing Medical University
ORCID:
0009-0002-9401-4130
Observed ORCID:
0009-0002-9401-4130
OpenAlex ID:
A5113404939
Automated Esophageal Cancer Staging From Free-Text Radiology Reports: Large Language Model Evaluation Study
2025
·
Yao Yao
, Xingxing Cen
, et al.
·
JMIR Medical Informatics
·
7
PDF
Early Safety of Ultra-Hypofractionated Whole Breast Irradiation and Sequential Tumor Bed Boost for Early Breast Cancer (SHIFT): A Multicenter, Phase 2 Trial
2026
·
Si-Yue Zheng
, Jia-Qi Huang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
PDF
Early Safety of Ultra-Hypofractionated Whole Breast Irradiation and Sequential Tumor Bed Boost for Early Breast Cancer (SHIFT): A Multicenter, Phase 2 Trial
2024
·
S. Zheng
, M. Dong
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
PDF
Abstract PD10-10: A Multicenter, Open-Label, Phase 2 Study of nab-Sirolimus (HB1901) Plus Endocrine Therapy in HR+/HER2- Advanced Breast Cancer Following Standard Therapy Failure
2026
·
F. Ma
, Q. Zhang
, et al.
·
Clinical Cancer Research
PLCG2 promotes cell survival and mitophagy of small cell lung cancer via regulating VCP
2025
·
Juan Jiang
, Ju Zhu
, et al.
·
Anti-Cancer Drugs
Show more works
View as search
Works count:
5
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type